Influence of neutrophil–lymphocyte ratio in prognosis of glioblastoma multiforme
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of neutrophil–lymphocyte ratio in prognosis of glioblastoma multiforme
Authors
Keywords
Glioblastoma multiforme, Neutrophil–lymphocyte ratio, Epidemiology, Overall survival, Progression-free survival
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 136, Issue 1, Pages 173-180
Publisher
Springer Nature
Online
2017-10-26
DOI
10.1007/s11060-017-2641-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival
- (2017) Peng-Fei Wang et al. Oncotarget
- A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors
- (2016) VS Madhugiri et al. Journal of Postgraduate Medicine
- Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
- (2016) Jun-Rui Chen et al. MEDICINE
- A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
- (2016) Wen Wang et al. Oncotarget
- Prognostic factors for glioblastoma patients - a clinical population-based study
- (2015) B. Fekete et al. ACTA NEUROLOGICA SCANDINAVICA
- Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma
- (2015) Sheng Han et al. BMC CANCER
- Increased Neutrophil to Lymphocyte Ratio in Patients With Resistant Hypertension
- (2015) Erdal Belen et al. Journal of Clinical Hypertension
- Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients
- (2015) Meiqin Lou et al. BMC Endocrine Disorders
- Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
- (2014) Mairéad G. McNamara et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- IDHMutations: Genotype-Phenotype Correlation and Prognostic Impact
- (2014) Xiao-Wei Wang et al. Biomed Research International
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma
- (2013) George A. Alexiou et al. JOURNAL OF NEURO-ONCOLOGY
- The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
- (2013) R. M. Bambury et al. JOURNAL OF NEURO-ONCOLOGY
- A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma
- (2013) C.-K. Park et al. NEURO-ONCOLOGY
- Immunomonitoring and prognostic relevance of neutrophils in clinical trials
- (2013) Frede Donskov SEMINARS IN CANCER BIOLOGY
- The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment
- (2012) Richard E. Kast et al. Anti-Cancer Agents in Medicinal Chemistry
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Prognostication in Advanced Cancer: A Study Examining an Inflammation-Based Score
- (2012) Michael Partridge et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- IDH Mutations in Human Glioma
- (2012) Won Kim et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
- (2011) Amy S. Darefsky et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
- (2011) Michael J. Proctor et al. EUROPEAN JOURNAL OF CANCER
- Effect of Uremia on Structure and Function of Immune System
- (2011) Nosratola D. Vaziri et al. JOURNAL OF RENAL NUTRITION
- Segregation of non-p.R132H mutations inIDH1in distinct molecular subtypes of glioma
- (2010) Lonneke A.M. Gravendeel et al. HUMAN MUTATION
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
- (2007) Thierry Gorlia et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started